The new post-coital contraceptive, ulipristal (also known as ella), has been FDA approved. As a doctor who wants women to have as many choices as possible, I’m thrilled to have another option to offer to women.  But this particular new choice actually leaves me feeling queasy.

The Board of Pharmacy for the state of Washington has officially submitted a proposal to rewrite its own rule, which mandated that pharmacies fill prescriptions "without delay or discrimination."

Is Washington State congressional candidate and former state senator, Dino Rossi, not anti-choice enough for his fellow GOP-ers?

On Friday, August 13th, 2010, the U.S. Food and Drug Administration (FDA) Advisory Committee for Reproductive Health Drugs approved the sale and use of "ella," the brand name for a new form of emergency contraception that will provide women with more options to prevent unplanned pregnancies.  Health advocates welcomed the news.

The Copper IUD as a form of emergency contraception? Researchers say it's almost 100% effective at preventing pregnancy if inserted five days after unprotected sex. But, honestly, is it feasible for most women to run to their doctor and have an IUD inserted "asap"?!

Suddenly and without warning the Washington state Board of Pharmacy has re-written the rules barring pharmacy refusal - rules decided with extensive public input three years ago.

The American Civil Liberties Union is demanding women have access to the full battery of reproductive health services, regardless of the hospital she enters.

An advisory committee of the Food and Drug Administration has found that a new emergency contraceptive is safe and effective, and labeling should not restrict access to product.

The FDA is considering approval of a new pregnancy prevention option.  Anti-choicers are, unsurprisingly, opposing approval of and expanded access to the method.

Emergency contraceptive pills (ECPs) are now available in many countries, but have failed to have the desired impact on unwanted pregnancy rates. Why is this? Earlier barriers to access are becoming less and less prevalent. A market for ECPs has been demonstrated and numerous manufacturers and distributors are keen to supply ECPs products; in many countries they are starting to be mainstreamed into norms, pre-service training, and services.